A neuroscience Ph.D. candidate at UC Davis acts as a bridge between scientists researching PURA syndrome and families seeking treatments, clarifying what CRISPR breakthroughs mean for rare diseases.

This discussion draws from Celena’s First Opinion essay and the First Opinion Podcast, with insights from Celena and STAT reporter Jason Mast on how parents can guide and accelerate research.

The piece emphasizes that input from parents and the broader community shapes research directions and helps ensure scientific advances meet real-world needs of rare-disease families.

The episode explains why CRISPR-based cures are especially challenging for PURA syndrome, using Baby KJ as a recent reference point in gene-editing news.

Celena argues that caregivers and patients must be actively engaged in the research process to push science forward and enable personalized treatments.

Families affected by rare diseases— including the PURA community—express urgent questions about when CRISPR therapies might be available, underscoring communication gaps between researchers and patients.